Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Antibiotic treatment of Lyme borreliosis: what is the evidence?

Dinser R, Jendro MC, Schnarr S, Zeidler H.

Ann Rheum Dis. 2005 Apr;64(4):519-23. Review.

2.

Dermatological manifestations of Lyme borreliosis.

Mullegger RR.

Eur J Dermatol. 2004 Sep-Oct;14(5):296-309. Review.

PMID:
15358567
3.

Lyme borreliosis.

Scarpa C, Trevisan G, Stinco G.

Dermatol Clin. 1994 Oct;12(4):669-85. Review.

PMID:
7805296
4.

[Lyme borreliosis].

Weiss M.

Ther Umsch. 1998 Jan;55(1):45-51. Review. German.

PMID:
9492618
5.

[Stage-oriented treatment of Lyme borreliosis].

Fingerle V, Wilske B.

MMW Fortschr Med. 2006 Jun 22;148(25):39-41. Review. German.

PMID:
16859159
6.

Lyme arthritis and post-Lyme disease syndrome.

Weinstein A, Britchkov M.

Curr Opin Rheumatol. 2002 Jul;14(4):383-7. Review.

PMID:
12118171
7.

[Guideline 'Lyme borreliosis'].

Speelman P, de Jongh BM, Wolfs TF, Wittenberg J; Kwaliteitsinstituut voor de Gezondheidszorg (CBO).

Ned Tijdschr Geneeskd. 2004 Apr 3;148(14):659-63. Dutch.

PMID:
15106316
8.

[Lyme borreliosis in adults].

Ljøstad U, Mygland A.

Tidsskr Nor Laegeforen. 2008 May 15;128(10):1175-8. Norwegian.

9.

Skin manifestations of lyme borreliosis: diagnosis and management.

Müllegger RR, Glatz M.

Am J Clin Dermatol. 2008;9(6):355-68. doi: 10.2165/0128071-200809060-00002. Review.

PMID:
18973402
10.

Solitary borrelial lymphocytoma in adult patients.

Maraspin V, Cimperman J, Lotric-Furlan S, Ruzić-Sabljić E, Jurca T, Picken RN, Strle F.

Wien Klin Wochenschr. 2002 Jul 31;114(13-14):515-23.

PMID:
12422593
11.

Treatment of Lyme disease.

[No authors listed]

Med Lett Drugs Ther. 1992 Oct 16;34(881):95-7. No abstract available.

PMID:
1406447
12.

Erythema migrans in the immunocompromised host.

Maraspin V, Lotric-Furlan S, Cimperman J, Ruzić-Sabljić E, Strle F.

Wien Klin Wochenschr. 1999 Dec 10;111(22-23):923-32.

PMID:
10666803
13.

[Lyme arthritis: the joint lesions in Lyme borreliosis in the USA].

Steere AC.

Ter Arkh. 1995;67(11):43-5. Russian.

PMID:
8571250
14.

Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.

Hunfeld KP, Ruzić-Sabljić E, Norris DE, Kraiczy P, Strle F.

Int J Med Microbiol. 2006 May;296 Suppl 40:233-41. Epub 2006 Mar 10. Review.

PMID:
16530006
15.

Lyme borreliosis treatment.

Vanousová D, Hercogová J.

Dermatol Ther. 2008 Mar-Apr;21(2):101-9. doi: 10.1111/j.1529-8019.2008.00177.x. Review.

PMID:
18394084
16.

[Reinfection in Lyme borreliosis].

Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Swierzbińska R, Moniuszko A, Pawlak-Zalewska W.

Pol Merkur Lekarski. 2008 Sep;25(147):257-9. Review. Polish.

PMID:
19112844
17.

A perspective on the treatment of Lyme borreliosis.

Luft BJ, Gorevic PD, Halperin JJ, Volkman DJ, Dattwyler RJ.

Rev Infect Dis. 1989 Sep-Oct;11 Suppl 6:S1518-25. Review.

PMID:
2682965
18.

[Dermatological aspects of Lyme borreliosis].

Lipsker D.

Med Mal Infect. 2007 Jul-Aug;37(7-8):540-7. Epub 2007 Mar 27. French.

PMID:
17391884
19.

[Antibiotic therapy of Lyme borreliosis].

Satz N, Knoblauch M.

Schweiz Med Wochenschr. 1990 Feb 17;120(7):209-16. Review. German.

PMID:
2408142
20.

Infection and musculoskeletal conditions: Lyme borreliosis.

Schnarr S, Franz JK, Krause A, Zeidler H.

Best Pract Res Clin Rheumatol. 2006 Dec;20(6):1099-118. Review.

PMID:
17127199
Items per page

Supplemental Content

Write to the Help Desk